Barts Health NHS Trust and Queen Mary University of London Medical School, London, United Kingdom., United Kingdom
Disclosure information not submitted.
The effectiveness of adalimumab biosimilars and originator for the treatment of Psoriasis: A target trial emulation study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Monday, August 26, 20245:25 PM – 5:30 PM CEST
